News Focus
News Focus
Post# of 257458
Next 10
Followers 843
Posts 122898
Boards Moderated 9
Alias Born 09/05/2002

Re: DewDiligence post# 243338

Wednesday, 02/28/2024 12:34:07 PM

Wednesday, February 28, 2024 12:34:07 PM

Post# of 257458
VANI—(+313%)—reports preclinical data for Exenatide implant:

https://www.businesswire.com/news/home/20240228342864/en

Everyone is chasing the obesity market. Caveat emptor.

VANI (f/k/a Nano Precision Medicine) is the result of a 2022 reverse-merger (#msg-169535742).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today